Ely Benaim
2018
In 2018, Ely Benaim earned a total compensation of $851.4K as Former Chief Medical Officer at Rexahn Pharmaceuticals, a 37% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $100,000 |
|---|---|
| Option Awards | $294,861 |
| Salary | $440,000 |
| Other | $16,500 |
| Total | $851,361 |
Benaim received $440K in salary, accounting for 52% of the total pay in 2018.
Benaim also received $100K in non-equity incentive plan, $294.9K in option awards and $16.5K in other compensation.
Rankings
In 2018, Ely Benaim's compensation ranked 9,930th out of 14,244 executives tracked by ExecPay. In other words, Benaim earned more than 30.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,930 out of 14,244 | 30th |
Division Manufacturing | 4,010 out of 5,765 | 30th |
Major group Chemicals And Allied Products | 1,507 out of 2,128 | 29th |
Industry group Drugs | 1,272 out of 1,817 | 30th |
Industry Pharmaceutical Preparations | 979 out of 1,391 | 30th |
Source: SEC filing on April 29, 2019.
Benaim's colleagues
We found three more compensation records of executives who worked with Ely Benaim at Rexahn Pharmaceuticals in 2018.